<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
51447-3002-1
</NDCCode>
<PackageDescription>
4.25 g in 1 TUBE (51447-3002-1)
</PackageDescription>
<NDC11Code>
51447-3002-01
</NDC11Code>
<ProductNDC>
51447-3002
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Octinoxate, Oxybenzone, Petrolatum
</NonProprietaryName>
<DosageFormName>
LIPSTICK
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20170102
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
SCRIBE OPCO INC., dba Koozie Group
</LabelerName>
<SubstanceName>
OXYBENZONE; PETROLATUM; OCTINOXATE
</SubstanceName>
<StrengthNumber>
35; 420; 75
</StrengthNumber>
<StrengthUnit>
mg/g; mg/g; mg/g
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2014-02-04
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20221231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
02-JAN-17
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>